University of California, San Diego: Dermatology Clinical Trials Unit
Welcome,         Profile    Billing    Logout  
 8 Trials 
12 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Leung, Donald
LEADS, NCT05436535: Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis

Recruiting
4
600
US
Dupilumab, Dupixent, Vanicream- Dupilumab-naïve, Triamcinolone Acetonide, Hydrocortisone, Vanicream- Active, Vanicream- Experienced Dupilumab
National Institute of Allergy and Infectious Diseases (NIAID)
Atopic Dermatitis
05/25
10/25
OUtMATCH, NCT03881696: Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants

Hourglass Jul 2023 - Dec 2023 : Data readout from P3 OUtMATCH trial for food allergy
Active, not recruiting
3
471
US
Omalizumab, Xolair®, Placebo for Omalizumab, Placebo, Multi-Allergen Oral Immunotherapy, Multi-Allergen OIT, Placebo for Multi-Allergen Oral Immunotherapy, Placebo for Multi-Allergen OIT, Double-Blind Placebo-Controlled Food Challenge Based Treatment, DBPCFC Based Treatment
National Institute of Allergy and Infectious Diseases (NIAID), Genentech, Inc., Novartis Pharmaceuticals, Rho Federal Systems Division, Inc.
Peanut Allergy, Multi-food Allergy
03/23
06/25
NCT06504160: Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)

Not yet recruiting
2
86
US
ShA9 Topical Gel, Hydrocortisone Ointment, Clobetasol Ointment, Fluocinonide Ointment, Placebo (Vehicle) Topical Gel
National Institute of Allergy and Infectious Diseases (NIAID), Atopic Dermatitis Research Network (ADRN), Rho Federal Systems Division, Inc., PPD, Thermo Fisher Scientific Inc.
Atopic Dermatitis
06/26
07/26
NCT03742414: Seal, Stopping Eczema and Allergy Study

Recruiting
2
312
Europe, US
Tri-lipid skin barrier cream (Epiceram), Fluticasone propionate Cream 0.05%, Standard of Care
Kari Nadeau, MD, PhD, King's College London and Guy's & St. Thomas Hospital, National Jewish Health, University of Chicago, Children's Hospital Medical Center, Cincinnati, Harvard School of Public Health (HSPH), Stanford University
Eczema, Infantile, Eczema, Atopic Dermatitis Eczema, Atopic Dermatitis
05/27
06/27
NCT04060550: Impact of Increased Immunoglobulin E to Anti-herpes Simplex Virus -1 Innate Immune Responses in Atopic Dermatitis Patients With Eczema Herpeticum

Recruiting
N/A
36
US
Xolair, omalizumab
National Jewish Health, Genentech, Inc.
Atopic Dermatitis With a History of Eczema Herpeticum, Atopic Dermatitis Without a History of Eczema Herpeticum, Health Controls Without Atopy
07/21
07/21
NCT04445298: Skin Barrier Assessment in Pregnancy and at Birth

Recruiting
N/A
160
US
Transepidermal water loss, TEWL, Skin tape stripping, STS, Blood draw, Bacterial PCR swab, PCR
National Jewish Health
Pregnancy Related, Allergy, Atopic Dermatitis Eczema, Asthma in Children, Food Allergy
07/22
07/22
NCT02910791: The Role of Bacterial Toxins in Human Skin Disease

Recruiting
N/A
100
US
National Jewish Health
Atopic Dermatitis, Psoriasis
12/22
12/23
SUNBEAM, NCT04798079: Systems Biology of Early Atopy

Recruiting
N/A
2500
US
National Institute of Allergy and Infectious Diseases (NIAID), Consortium for Food Allergy Research, Rho Federal Systems Division, Inc.
Allergic Diseases, Food Allergy, Atopic Dermatitis
09/28
09/28
Gallo, Richard
NCT06504160: Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)

Not yet recruiting
2
86
US
ShA9 Topical Gel, Hydrocortisone Ointment, Clobetasol Ointment, Fluocinonide Ointment, Placebo (Vehicle) Topical Gel
National Institute of Allergy and Infectious Diseases (NIAID), Atopic Dermatitis Research Network (ADRN), Rho Federal Systems Division, Inc., PPD, Thermo Fisher Scientific Inc.
Atopic Dermatitis
06/26
07/26
TIME-1, NCT05177328: Targeted Investigation of Microbiome Elimination

Terminated
1
21
US
S. hominis A 9 Product, ShA9, Placebo, Placebo for S. hominis A 9 Product
National Institute of Allergy and Infectious Diseases (NIAID), Atopic Dermatitis Research Network
Atopic Dermatitis
08/23
10/23
Fernandez-Desoto, Alexandra
LEADS, NCT05436535: Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis

Recruiting
4
600
US
Dupilumab, Dupixent, Vanicream- Dupilumab-naïve, Triamcinolone Acetonide, Hydrocortisone, Vanicream- Active, Vanicream- Experienced Dupilumab
National Institute of Allergy and Infectious Diseases (NIAID)
Atopic Dermatitis
05/25
10/25
NCT06504160: Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)

Not yet recruiting
2
86
US
ShA9 Topical Gel, Hydrocortisone Ointment, Clobetasol Ointment, Fluocinonide Ointment, Placebo (Vehicle) Topical Gel
National Institute of Allergy and Infectious Diseases (NIAID), Atopic Dermatitis Research Network (ADRN), Rho Federal Systems Division, Inc., PPD, Thermo Fisher Scientific Inc.
Atopic Dermatitis
06/26
07/26

Download Options